Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C001079 |
2-(2,6-dioxopiperidin-3-yl)phthalimidine |
2-(2,6-dioxopiperidin-3-yl)phthalimidine results in decreased expression of ITGAL protein | decreases expression | 8538367
|
D000584 |
Amiloride |
Amiloride inhibits the reaction [TNF protein results in increased expression of ITGAL mRNA] | decreases reaction|increases expression | 10198263
|
D000584 |
Amiloride |
Amiloride inhibits the reaction [TNF protein results in increased expression of ITGAL protein] | decreases reaction|increases expression | 10198263
|
D015081 |
2-Naphthylamine |
2-Naphthylamine results in decreased expression of ITGAL mRNA | decreases expression | 18247414
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of ITGAL mRNA | affects expression | 16483693
|
C015001 |
arsenite |
arsenite results in decreased expression of ITGAL mRNA | decreases expression | 18191166
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of ITGAL mRNA | decreases expression | 18247414
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of ITGAL mRNA | decreases expression | 12419474
|
D002392 |
Catechin |
Catechin results in increased expression of ITGAL mRNA | increases expression | 15465739
|
D017308 |
Etodolac |
Etodolac results in decreased expression of ITGAL protein | decreases expression | 16046235
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of ITGAL mRNA | increases expression | 15465739
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in decreased expression of ITGAL mRNA | decreases expression | 12419474
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of ITGAL mRNA | increases expression | 10198263
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of ITGAL protein | increases expression | 10198263
|
D008070 |
Lipopolysaccharides |
Staurosporine inhibits the reaction [Lipopolysaccharides results in increased expression of ITGAL mRNA] | decreases reaction|increases expression | 10198263
|
D008070 |
Lipopolysaccharides |
Staurosporine inhibits the reaction [Lipopolysaccharides results in increased expression of ITGAL protein] | decreases reaction|increases expression | 10198263
|
D009538 |
Nicotine |
Nicotine results in decreased expression of ITGAL mRNA | decreases expression | 18247414
|
D010654 |
Phenylbutyrates |
Phenylbutyrates promotes the reaction [Tretinoin results in increased expression of ITGAL protein] | increases expression|increases reaction | 18055984
|
D010936 |
Plant Extracts |
Plant Extracts results in increased expression of ITGAL mRNA | increases expression | 15465739
|
C025299 |
polyphenols |
polyphenols results in increased expression of ITGAL mRNA | increases expression | 15465739
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in decreased expression of ITGAL mRNA] | affects cotreatment|decreases expression|decreases reaction | 16267019
|
D019311 |
Staurosporine |
Staurosporine inhibits the reaction [Lipopolysaccharides results in increased expression of ITGAL mRNA] | decreases reaction|increases expression | 10198263
|
D019311 |
Staurosporine |
Staurosporine inhibits the reaction [Lipopolysaccharides results in increased expression of ITGAL protein] | decreases reaction|increases expression | 10198263
|
D019311 |
Staurosporine |
Staurosporine inhibits the reaction [TNF protein results in increased expression of ITGAL mRNA] | decreases reaction|increases expression | 10198263
|
D019311 |
Staurosporine |
Staurosporine inhibits the reaction [TNF protein results in increased expression of ITGAL protein] | decreases reaction|increases expression | 10198263
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of ITGAL mRNA | increases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased activity of ITGAL | decreases activity | 17201180
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of ITGAL | decreases expression | 17201180
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of ITGAL protein | decreases expression | 15310856
|
D014212 |
Tretinoin |
CSF3 protein promotes the reaction [Tretinoin results in increased expression of ITGAL protein] | increases expression|increases reaction | 18055984
|
D014212 |
Tretinoin |
Phenylbutyrates promotes the reaction [Tretinoin results in increased expression of ITGAL protein] | increases expression|increases reaction | 18055984
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of ITGAL protein | increases expression | 18055984
|
C025643 |
vinclozolin |
vinclozolin affects the expression of ITGAL mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
2-(2,6-dioxopiperidin-3-yl)phthalimidine |
8.74 | 473085 3196154 6734493 3355362 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.74 | 14514962 11752688 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.45 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.75 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
3.93 | 11850527 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
2-(2,6-dioxopiperidin-3-yl)phthalimidine |
5.06 | 1933837 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
5.06 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
6.59 | 6695378 |
MESH:D000236 |
Adenoma |
|
resveratrol |
6.59 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.27 | 16835633 |
OMIM:607154 |
ALLERGIC RHINITIS |
|
Etodolac |
5.71 | 16979129 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.53 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Nicotine |
6.75 | 16627626 |
MESH:D000544 |
Alzheimer Disease |
|
Plant Extracts |
6.75 | 16962711 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
6.75 | 16183991 16162502 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.85 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.55 | 19015723 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.96 | 19183758 |
MESH:D001169 |
Arthritis, Experimental |
|
2-(2,6-dioxopiperidin-3-yl)phthalimidine |
17.14 | 9598899 |
MESH:D001169 |
Arthritis, Experimental |
|
Plant Extracts |
17.14 | 14686799 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
17.14 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
17.14 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.24 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.31 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.21 | 17967414 16873680 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.29 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.60 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
8.60 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.69 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
2-(2,6-dioxopiperidin-3-yl)phthalimidine |
8.58 | 3355362 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.58 | 15746008 |
MESH:D002545 |
Brain Ischemia |
|
Plant Extracts |
10.11 | 16041641 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
10.11 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.93 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
1.93 | 17651959 16393696 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.93 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.93 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.48 | 16813970 |
MESH:D002057 |
Burns, Chemical |
|
Plant Extracts |
5.23 | 9625245 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.71 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.05 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Plant Extracts |
4.69 | 18834353 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
4.69 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
4.69 | 1917145 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.48 | 16675471 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
7.37 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
7.37 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
7.37 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Amiloride |
4.98 | 14644129 |
MESH:D006332 |
Cardiomegaly |
|
Plant Extracts |
6.78 | 17645561 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.78 | 18850075 18670907 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
7.34 | 16936243 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
7.34 | 15458977 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.03 | 17460283 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.48 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.07 | 16835633 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.05 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.61 | 16354765 8697196 12621046 15340226 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.61 | 9407595 |
MESH:D003092 |
Colitis |
|
Amiloride |
15.59 | 12065299 |
MESH:D003092 |
Colitis |
|
resveratrol |
15.59 | 16474422 |
MESH:D003092 |
Colitis |
|
Tretinoin |
15.59 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
2-(2,6-dioxopiperidin-3-yl)phthalimidine |
10.98 | 1933837 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
10.98 | 15037631 |
MESH:D003110 |
Colonic Neoplasms |
|
Etodolac |
10.98 | 16004971 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
10.98 | 16293270 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
10.98 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
Etodolac |
3.29 | 11076880 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
3.29 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.96 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.68 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.41 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.41 | 9211117 16925845 9664655 17551590 9224671 10589399 9142499 8800419 9125849 14991402 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.23 | 14966744 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.68 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.64 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Plant Extracts |
9.07 | 19706694 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
9.07 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
3.88 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.88 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.68 | 11462148 |
MESH:D020821 |
Dystonic Disorders |
|
Nicotine |
5.82 | 17881519 |
MESH:D004480 |
Ectromelia |
|
2-(2,6-dioxopiperidin-3-yl)phthalimidine |
6.94 | 7940403 |
MESH:D004487 |
Edema |
|
Plant Extracts |
15.73 | 12787963 |
MESH:D004487 |
Edema |
|
resveratrol |
15.73 | 8985016 |
MESH:D004487 |
Edema |
|
Staurosporine |
15.73 | 8273558 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
15.73 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.59 | 15322242 16714409 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.59 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
3.92 | 17872969 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.04 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.92 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Plant Extracts |
5.58 | 15268973 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.29 | 15328337 17637181 15821434 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.74 | 17923197 |
MESH:D004827 |
Epilepsy |
|
Plant Extracts |
3.67 | 19700373 19439326 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
1.98 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.56 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.56 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
8.05 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
Plant Extracts |
8.05 | 15975614 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.35 | 11858732 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.91 | 11852909 9205823 |
MESH:D005355 |
Fibrosis |
|
arsenite |
14.21 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
14.21 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
14.21 | 17994277 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.83 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.19 | 16417039 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
2.93 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.49 | 10696789 |
MESH:D006130 |
Growth Disorders |
|
Amiloride |
4.68 | 19703807 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.11 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.05 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
10.76 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.76 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
10.76 | 14991402 9664655 |
MESH:D006333 |
Heart Failure |
|
Plant Extracts |
3.80 | 18097624 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.28 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.23 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.78 | 12621046 16120746 15340226 |
MESH:D006561 |
Herpes Simplex |
|
Plant Extracts |
9.76 | 10715843 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
9.76 | 16876885 |
MESH:D015658 |
HIV Infections |
|
Plant Extracts |
3.62 | 12878215 |
MESH:D019584 |
Hot Flashes |
|
Plant Extracts |
4.64 | 14716179 16566672 17454163 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.94 | 16959395 8697196 18606429 15340226 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.12 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.90 | 17188708 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.46 | 16778211 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Catechin |
9.61 | 17292331 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Plant Extracts |
9.61 | 16484555 |
MESH:D006949 |
Hyperlipidemias |
|
Plant Extracts |
9.26 | 15268973 15975614 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
9.26 | 16873680 |
MESH:D006973 |
Hypertension |
|
Amiloride |
5.46 | 18524855 19344079 15174897 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.46 | 18670907 18850075 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.20 | 17488730 |
MESH:D020514 |
Hypokalemic Periodic Paralysis |
|
Amiloride |
5.74 | 19822448 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.54 | 17600658 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
2.97 | 16467254 |
MESH:D007249 |
Inflammation |
|
Amiloride |
23.41 | 17237260 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
23.41 | 17296493 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
23.41 | 17963957 12878042 9205823 17237260 17255318 |
MESH:D007249 |
Inflammation |
|
Plant Extracts |
23.41 | 12787963 19332304 15997105 16366677 |
MESH:D007249 |
Inflammation |
|
polyphenols |
23.41 | 16366677 |
MESH:D007249 |
Inflammation |
|
resveratrol |
23.41 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
23.41 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.44 | 16624496 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.66 | 17994277 |
MESH:D007414 |
Intestinal Neoplasms |
|
Plant Extracts |
4.52 | 12351151 12584176 12628509 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.53 | 17255318 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.59 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.59 | 15992940 17551590 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
4.17 | 16518626 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.72 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.60 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.06 | 19850784 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
marker/mechanism |
|
| 16764927 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
7.53 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
7.53 | 17339181 16766008 9834237 17368321 17294898 16140955 17361223 17217047 16891316 17506722 17649720 12679006 17712046 19029980 19642359 15748426 16788101 19225113 16823087 16331271 19075265 16935935 19035177 17301526 17107899 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.59 | 15821434 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.62 | 16417039 |
MESH:D056929 |
Liddle Syndrome |
|
Amiloride |
5.86 | 19344079 |
MESH:D017880 |
Limb Deformities, Congenital |
|
2-(2,6-dioxopiperidin-3-yl)phthalimidine |
8.69 | 3355362 6734493 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
8.69 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
6.97 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Plant Extracts |
6.97 | 17157831 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
4.90 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Plant Extracts |
4.90 | 15479170 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.90 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
4.90 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Plant Extracts |
4.57 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
4.57 | 16698588 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
10.41 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Plant Extracts |
10.41 | 19168119 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
10.41 | 19812893 19321006 20405173 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.41 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.04 | 12151625 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.90 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
4.79 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
4.79 | 20869020 17053015 18569708 18520028 20464547 20135361 18816296 20064080 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Plant Extracts |
4.79 | 20869020 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.79 | 19555203 11884234 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.19 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.78 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.14 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
3.04 | 8985016 11606380 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.74 | 17453147 |
MESH:D008545 |
Melanoma |
|
resveratrol |
3.40 | 17992120 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.40 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.32 | 16940565 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.27 | 17112576 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.10 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
3.39 | 16490592 17935668 17049120 16267019 14749477 17164350 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.76 | 17962980 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.02 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
2.98 | 17188708 17125593 16525036 16456233 16317513 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
8.72 | 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.72 | 12213967 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.65 | 17322642 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Amiloride |
5.19 | 14644129 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
8.09 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Nicotine |
8.09 | 16365874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
8.09 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
3.89 | 8985016 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
10.25 | 15738583 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Nicotine |
10.25 | 16365874 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.15 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
9.15 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
2.98 | 9142499 |
MESH:D019954 |
Neurobehavioral Manifestations |
|
Plant Extracts |
5.07 | 17168769 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
3.72 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.29 | 17929310 |
MESH:D009765 |
Obesity |
|
Plant Extracts |
3.12 | 20132043 19056576 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.15 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.31 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.81 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.42 | 15976015 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
9.32 | 12065085 |
MESH:D010212 |
Papilloma |
|
Plant Extracts |
9.32 | 16517061 15173996 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.14 | 12520081 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.45 | 11605937 12224865 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.45 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
15.66 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
15.66 | 11222880 11896295 11399792 11118676 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
15.66 | 18042343 18220299 19015723 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.83 | 18220299 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.74 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Plant Extracts |
2.74 | 17804756 14666653 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.74 | 17804756 16731767 17636462 17718901 17675339 15767336 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.83 | 18629315 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.50 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.68 | 16723453 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.48 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
3.22 | 16314181 17520802 17058453 16317513 15827377 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.66 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.73 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.99 | 16283617 16116481 |
MESH:D012640 |
Seizures |
|
Nicotine |
3.72 | 17873105 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
26.44 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
26.44 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
Plant Extracts |
26.44 | 15173996 16517061 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
26.44 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
26.44 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
26.44 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
26.44 | 16467112 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.32 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.32 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Plant Extracts |
3.80 | 17135157 12787963 18193104 15255614 18237397 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.38 | 16321402 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
Plant Extracts |
12.92 | 17997062 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
12.92 | 17997062 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.07 | 15821434 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.80 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
2.94 | 16026305 17045167 |
OMIM:188890 |
TOBACCO ADDICTION, SUSCEPTIBILITY TO |
|
Nicotine |
4.65 | 16720336 11259349 16785264 |
MESH:D014029 |
Tobacco Use Disorder |
|
Nicotine |
5.34 | 15735609 18305452 17979512 18041664 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
9.58 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
9.58 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.16 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2-Naphthylamine |
5.36 | 11144890 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.36 | 17053015 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
9.21 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
9.21 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
4.03 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.50 | 16752155 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.49 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Plant Extracts |
10.17 | 18097624 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
10.17 | 17488730 |
MESH:D020257 |
Ventricular Remodeling |
|
Plant Extracts |
5.21 | 18097624 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.95 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.14 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.87 | 16287080 |
MESH:D014947 |
Wounds and Injuries |
|
Plant Extracts |
4.16 | 20213670 19894650 |